Ignite Creation Date:
2024-05-06 @ 2:14 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04256941
Status:
COMPLETED
Last Update Posted:
2024-04-16
First Post:
2020-01-21
Brief Title:
Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation the INTERACT Study
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-31
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-22
Completion Date Type:
ACTUAL
First Submit Date:
2020-01-21
First Submit QC Date:
February 4 2020
Study First Post Date:
2020-02-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-15
Last Update Post Date:
2024-04-16
Last Update Post Date Type:
ACTUAL